AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Kreklau, EL Limp-Foster, M Liu, NL Xu, Y Kelley, MR Erickson, LC
Citation: El. Kreklau et al., A novel fluorometric oligonucleotide assay to measure O-6-methylguanine DNA methyltransferase, methylpurine DNA glycosylase, 8-oxoguanine DNA glycosylase and abasic endonuclease activities: DNA repair status in human breast carcinoma cells overexpressing methylpurine DNA glycosylase, NUCL ACID R, 29(12), 2001, pp. 2558-2566

Authors: Erickson, LC Hawthorne, HM Troczynski, T
Citation: Lc. Erickson et al., Correlations between microstructural parameters, micromechanical properties and wear resistance of plasma sprayed ceramic coatings, WEAR, 250, 2001, pp. 569-575

Authors: Bacha, EA Scheule, AM Zurakowski, D Erickson, LC Hung, J Lang, P Mayer, JE del Nido, PJ Jonas, RA
Citation: Ea. Bacha et al., Long-term results after early primary repair of tetralogy of Fallot, J THOR SURG, 122(1), 2001, pp. 154-161

Authors: Zhang, QW Ohannesian, DW Kreklau, EL Erickson, LC
Citation: Qw. Zhang et al., Modulation of 1,3-bis-(2-chloroethyl)-1-nitrosourea resistance in human tumor cells using hammerhead ribozymes designed to degrade O-6-methylguanine DNA methyltransferase mRNA, J PHARM EXP, 298(1), 2001, pp. 141-147

Authors: Kreklau, EL Liu, NL Li, ZH Cornetta, K Erickson, LC
Citation: El. Kreklau et al., Comparison of single- versus double-bolus treatments of O-6-benzylguanine for depletion of O-6-methylguanine DNA methyltransferase (MGMT) activity invivo: Development of a novel fluorometric oligonucleotide assay for measurement of MGMT activity, J PHARM EXP, 297(2), 2001, pp. 524-530

Authors: Williams, DA Maze, R Kurpad, C Pegg, A Erickson, LC
Citation: Da. Williams et al., Protection of hematopoietic cells against combined O-6-benzylguanine and chloroethylnitrosourea treatment by mutant forms of O-6-methylguanine DNA methyltransferase, BONE MAR TR, 25, 2000, pp. S105-S109

Authors: Erickson, LC Torchiana, DF Schneider, EC Newburger, JW Hannan, EL
Citation: Lc. Erickson et al., The relationship between managed care insurance and use of lower-mortalityhospitals for CABG surgery, J AM MED A, 283(15), 2000, pp. 1976-1982

Authors: Erickson, LC Wise, PH Cook, EF Beiser, A Newburger, JW
Citation: Lc. Erickson et al., The impact of managed care insurance on use of lower-mortality hospitals by children undergoing cardiac surgery in California, PEDIATRICS, 105(6), 2000, pp. 1271-1278

Authors: Rhee, EK Evangelista, JK Nigrin, DJ Erickson, LC
Citation: Ek. Rhee et al., Impact of anatomic closure on somatic growth among small, asymptomatic children with secundum atrial septal defect, AM J CARD, 85(12), 2000, pp. 1472-1475

Authors: Erickson, LC Troczynski, T Hawthorne, HM Tai, H Ross, D
Citation: Lc. Erickson et al., Alumina coatings by plasma spraying of monosize sapphire particles, J THERM SPR, 8(3), 1999, pp. 421-426

Authors: Kreklau, EL Kurpad, C Williams, DA Erickson, LC
Citation: El. Kreklau et al., Prolonged inhibition of O-6-methylguanine DNA methyltransferase in human tumor cells by O-6-benzylguanine in vitro and in vivo, J PHARM EXP, 291(3), 1999, pp. 1269-1275

Authors: Maze, R Kurpad, C Pegg, AE Erickson, LC Williams, DA
Citation: R. Maze et al., Retroviral-mediated expression of the P140A, but not P140A/G156A, mutant form of O-6-methylguanine DNA methyltransferase protects hematopoietic cellsagainst O-6-benzylguanine sensitization to chloroethylnitrosourea treatment, J PHARM EXP, 290(3), 1999, pp. 1467-1474
Risultati: 1-12 |